Reticulon 4 Antikörper (N-Term)
Kurzübersicht für Reticulon 4 Antikörper (N-Term) (ABIN2475901)
Target
Alle Reticulon 4 (RTN4) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Maus, Ratte (Rattus)
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
-
-
: "Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS." in: Nature neuroscience, Vol. 15, Issue 1, pp. 98-106, (2011) (PubMed).
: "Reticulon proteins: emerging players in neurodegenerative diseases." in: Cellular and molecular life sciences : CMLS, Vol. 63, Issue 7-8, pp. 877-89, (2006) (PubMed).
: "Nogo in the injured spinal cord." in: Journal of neurotrauma, Vol. 23, Issue 3-4, pp. 384-96, (2006) (PubMed).
-
: "Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS." in: Nature neuroscience, Vol. 15, Issue 1, pp. 98-106, (2011) (PubMed).
-
- Reticulon 4 (RTN4)
-
Andere Bezeichnung
- NOGOA
-
Gen-ID
- 57142
-
UniProt
- Q9NQC3
-
Pathways
- Neurotrophin Signalübertragung, Regulation of Cell Size, SARS-CoV-2 Protein Interaktom
Target
-